KOSPI and KOSDAQ listed pharmas had more than 10% growths in sales
The KOSPI and KOSDAQ listed pharmaceutical companies’ average collective sales were increased by more than 10% in the 3rd quarter compared to the same quarter of the last year. On the other hand, their 3rd quarter’s sales growth rates were dropped against the last quarter, but increased against t...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
